Johnson Matthey (JMPLY) and Its Rivals Head-To-Head Analysis

Johnson Matthey (OTCMKTS: JMPLY) is one of 24 publicly-traded companies in the “Chemicals & allied products” industry, but how does it compare to its rivals? We will compare Johnson Matthey to similar companies based on the strength of its dividends, institutional ownership, risk, earnings, analyst recommendations, profitability and valuation.

Risk and Volatility

How to Become a New Pot Stock Millionaire

Johnson Matthey has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Comparatively, Johnson Matthey’s rivals have a beta of 1.07, meaning that their average share price is 7% more volatile than the S&P 500.


Johnson Matthey pays an annual dividend of $2.00 per share and has a dividend yield of 2.2%. Johnson Matthey pays out 36.4% of its earnings in the form of a dividend. As a group, “Chemicals & allied products” companies pay a dividend yield of 1.6% and pay out 30.7% of their earnings in the form of a dividend.

Earnings and Valuation

This table compares Johnson Matthey and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Johnson Matthey $15.73 billion $504.61 million 16.73
Johnson Matthey Competitors $7.12 billion $610.16 million 24.48

Johnson Matthey has higher revenue, but lower earnings than its rivals. Johnson Matthey is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Johnson Matthey and its rivals, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Johnson Matthey 1 0 2 0 2.33
Johnson Matthey Competitors 101 465 684 26 2.50

As a group, “Chemicals & allied products” companies have a potential upside of 14.84%. Given Johnson Matthey’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Johnson Matthey has less favorable growth aspects than its rivals.

Institutional and Insider Ownership

0.0% of Johnson Matthey shares are owned by institutional investors. Comparatively, 76.3% of shares of all “Chemicals & allied products” companies are owned by institutional investors. 5.3% of shares of all “Chemicals & allied products” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.


This table compares Johnson Matthey and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Johnson Matthey N/A N/A N/A
Johnson Matthey Competitors -119.34% 22.18% 4.99%


Johnson Matthey rivals beat Johnson Matthey on 9 of the 14 factors compared.

About Johnson Matthey

Johnson Matthey Plc operates as a specialty chemicals company in North America, Europe, China, rest of Asia, and internationally. It operates in five divisions: Emission Control Technologies, Process Technologies, Precious Metal Products, Fine Chemicals, and New Businesses. The Emission Control Technologies division manufactures catalysts, which control harmful emissions from cars and other light duty vehicles powered by various types of fuel, as well as from diesel powered trucks, buses, and non-road machinery. The Process Technologies division manufactures catalysts, additives, and absorbents, as well as licenses process technologies; and delivers services to the petrochemical, biochemical, syngas, oil refining, and gas processing industries. The Precious Metal Products division manages, distributes, refines, and recycles precious metals and other special material using precious metals or related materials, platinum group metal catalysts, and platinum group metal chemicals for automotive and chemical markets; and develops and manufactures functional coatings and inks. The Fine Chemicals division develops and manufactures active pharmaceutical ingredients for various treatments, including pain management and attention deficit hyperactivity disorders; and specialty chemical, chiral, and biocatalytic technologies and products, as well as provides custom pharmaceutical research, development, and manufacturing services. This division also offers catalyst technologies for pharmaceutical, agrochemical, flavor, and fragrance applications. The New Businesses division is involved in the research, development, and manufacture of battery materials; design and supply of battery systems; and development and manufacture of catalysts and components for fuel cell markets. The company was formerly known as Johnson & Cock and changed its name to Johnson Matthey Plc in 1851. Johnson Matthey Plc was founded in 1817 and is based in London, the United Kingdom.

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with's FREE daily email newsletter.

Leave a Reply